Primary Cardiac Lymphoma in an Immunocompetent 71-Year-Old Man.
Isolated cardiac lymphomas are very rare, especially in immunocompetent patients. As a consequence, little is known about the best therapeutic management and about patients' outcomes in these cases. Diffuse large B-cell lymphoma is the most frequent subtype; anthracycline-based chemotherapy has been the most successful treatment. We describe the case of a primary cardiac lymphoma in an immunocompetent 71-year-old man. As of December 2015, the patient had been in clinical remission for 2 years. The most relevant literature on primary cardiac lymphoma is reported and discussed.
['Montanaro|Claudia|C|', 'Loiacono|Ferdinando|F|', 'Fragasso|Gabriele|G|', 'De Cobelli|Francesco|F|', 'Foppoli|Marco|M|', 'Margonato|Alberto|A|']
D000368:Aged D058846:Antibodies, Monoclonal, Murine-Derived D000971:Antineoplastic Combined Chemotherapy Protocols D003520:Cyclophosphamide D004317:Doxorubicin D006338:Heart Neoplasms D006801:Humans D007121:Immunocompetence D016403:Lymphoma, Large B-Cell, Diffuse D008297:Male D011241:Prednisone D012074:Remission Induction D000069283:Rituximab D013997:Time Factors D014057:Tomography, X-Ray Computed D016896:Treatment Outcome D014750:Vincristine
immunocompetence Biopsy, endomyocardial cyclophosphamide etoposide heart neoplasms/therapy lymphoma, large B-cell, diffuse/diagnosis/drug therapy lymphoma, non-Hodgkin/drug therapy prednisone rituximab vincristine